A Phase I/IIa trial to evaluate oral testosterone product TSX-011 in japanese patients.
Phase of Trial: Phase I/II
Latest Information Update: 03 May 2017
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Adverse reactions; Therapeutic Use
- 03 May 2017 New trial record
- 27 Apr 2017 According to a TesoRx media release, the company anticipate that this study will be conducted in the US later this year, and will include Japanese patients to expedite development in both regions.